Compared with other groups, participants in group 5 were more likely to be older; men; have hypertension, diabetes mellitus, and dyslipidemia; more likely to take antihypertensive, hypoglycemic, and hypolipidemic medications; and have a higher level of BMI, SBP, DBP, LDL-C, and Hs-CRP. This evidence concerns the gene CRP and metabolic syndrome.